VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Advancements in prognostic biomarkers for personalized therapy in multiple myeloma

Siobhan Glavey, MD, PhD, Royal College of Surgeons in Ireland, Dublin, Ireland, explains that molecular technologies have enabled the investigation of several prognostic biomarkers for multiple myeloma. Subsequently, this has aided in predicting survival outcomes and treatment response in patients with multiple myeloma. Prof. Glavey further discusses how the integration of these biomarkers into routine diagnostic strategies for multiple myeloma is needed to allow patients to receive more personalized therapies in the future. This interview was recorded virtually.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter